232.jpg)
Serum Institute of India's (SII) CEO Adar Poonawalla has said that a COVID-19 vaccine that specifically targets the Omicron variant is expected in India in the next six months, reports said on Monday. SII is the world's biggest vaccine maker and it manufactures the Oxford/AstraZeneca COVID-19 vaccine, sold as Covishield in India.
Editor In Chief : Dr Dhimant Purohit
Know your world in 60 words - Read News in just 1 minute
Hot Topics
Select the content to hear the Audio
